Table of Contents 1 Cognitive and Memory Enhancer Drugs Market Overview 1.1 Product Overview and Scope of Cognitive and Memory Enhancer Drugs 1.2 Cognitive and Memory Enhancer Drugs Segment by Type 1.2.1 Global Cognitive and Memory Enhancer Drugs Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Aricept 1.2.3 Exelon 1.2.4 Namenda 1.2.5 Razadyne 1.2.6 Provigil 1.2.7 Ritalin 1.2.8 Adderall 1.2.9 Others 1.3 Cognitive and Memory Enhancer Drugs Segment by Application 1.3.1 Cognitive and Memory Enhancer Drugs Sales Comparison by Application: 2020 VS 2026 1.3.2 Disease Treatment 1.3.3 Academic Performance 1.3.4 Athletic Performance 1.3.5 Others 1.4 Global Cognitive and Memory Enhancer Drugs Market Size Estimates and Forecasts 1.4.1 Global Cognitive and Memory Enhancer Drugs Revenue 2015-2026 1.4.2 Global Cognitive and Memory Enhancer Drugs Sales 2015-2026 1.4.3 Cognitive and Memory Enhancer Drugs Market Size by Region: 2020 Versus 2026 2 Global Cognitive and Memory Enhancer Drugs Market Competition by Manufacturers 2.1 Global Cognitive and Memory Enhancer Drugs Sales Market Share by Manufacturers (2015-2020) 2.2 Global Cognitive and Memory Enhancer Drugs Revenue Share by Manufacturers (2015-2020) 2.3 Global Cognitive and Memory Enhancer Drugs Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Cognitive and Memory Enhancer Drugs Manufacturing Sites, Area Served, Product Type 2.5 Cognitive and Memory Enhancer Drugs Market Competitive Situation and Trends 2.5.1 Cognitive and Memory Enhancer Drugs Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Cognitive and Memory Enhancer Drugs Players (Opinion Leaders) 3 Cognitive and Memory Enhancer Drugs Retrospective Market Scenario by Region 3.1 Global Cognitive and Memory Enhancer Drugs Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Cognitive and Memory Enhancer Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Cognitive and Memory Enhancer Drugs Market Facts & Figures by Country 3.3.1 North America Cognitive and Memory Enhancer Drugs Sales by Country 3.3.2 North America Cognitive and Memory Enhancer Drugs Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Cognitive and Memory Enhancer Drugs Market Facts & Figures by Country 3.4.1 Europe Cognitive and Memory Enhancer Drugs Sales by Country 3.4.2 Europe Cognitive and Memory Enhancer Drugs Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Cognitive and Memory Enhancer Drugs Market Facts & Figures by Region 3.5.1 Asia Pacific Cognitive and Memory Enhancer Drugs Sales by Region 3.5.2 Asia Pacific Cognitive and Memory Enhancer Drugs Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Cognitive and Memory Enhancer Drugs Market Facts & Figures by Country 3.6.1 Latin America Cognitive and Memory Enhancer Drugs Sales by Country 3.6.2 Latin America Cognitive and Memory Enhancer Drugs Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Cognitive and Memory Enhancer Drugs Market Facts & Figures by Country 3.7.1 Middle East and Africa Cognitive and Memory Enhancer Drugs Sales by Country 3.7.2 Middle East and Africa Cognitive and Memory Enhancer Drugs Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Cognitive and Memory Enhancer Drugs Historic Market Analysis by Type 4.1 Global Cognitive and Memory Enhancer Drugs Sales Market Share by Type (2015-2020) 4.2 Global Cognitive and Memory Enhancer Drugs Revenue Market Share by Type (2015-2020) 4.3 Global Cognitive and Memory Enhancer Drugs Price Market Share by Type (2015-2020) 4.4 Global Cognitive and Memory Enhancer Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Cognitive and Memory Enhancer Drugs Historic Market Analysis by Application 5.1 Global Cognitive and Memory Enhancer Drugs Sales Market Share by Application (2015-2020) 5.2 Global Cognitive and Memory Enhancer Drugs Revenue Market Share by Application (2015-2020) 5.3 Global Cognitive and Memory Enhancer Drugs Price by Application (2015-2020) 6 Company Profiles and Key Figures in Cognitive and Memory Enhancer Drugs Business 6.1 Pfizer 6.1.1 Corporation Information 6.1.2 Pfizer Description, Business Overview and Total Revenue 6.1.3 Pfizer Cognitive and Memory Enhancer Drugs Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Pfizer Products Offered 6.1.5 Pfizer Recent Development 6.2 Eisai Co 6.2.1 Eisai Co Cognitive and Memory Enhancer Drugs Production Sites and Area Served 6.2.2 Eisai Co Description, Business Overview and Total Revenue 6.2.3 Eisai Co Cognitive and Memory Enhancer Drugs Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Eisai Co Products Offered 6.2.5 Eisai Co Recent Development 6.3 Allergan 6.3.1 Allergan Cognitive and Memory Enhancer Drugs Production Sites and Area Served 6.3.2 Allergan Description, Business Overview and Total Revenue 6.3.3 Allergan Cognitive and Memory Enhancer Drugs Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Allergan Products Offered 6.3.5 Allergan Recent Development 6.4 Novartis 6.4.1 Novartis Cognitive and Memory Enhancer Drugs Production Sites and Area Served 6.4.2 Novartis Description, Business Overview and Total Revenue 6.4.3 Novartis Cognitive and Memory Enhancer Drugs Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Novartis Products Offered 6.4.5 Novartis Recent Development 6.5 Takeda 6.5.1 Takeda Cognitive and Memory Enhancer Drugs Production Sites and Area Served 6.5.2 Takeda Description, Business Overview and Total Revenue 6.5.3 Takeda Cognitive and Memory Enhancer Drugs Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Takeda Products Offered 6.5.5 Takeda Recent Development 6.6 Johnson & Johnson 6.6.1 Johnson & Johnson Cognitive and Memory Enhancer Drugs Production Sites and Area Served 6.6.2 Johnson & Johnson Description, Business Overview and Total Revenue 6.6.3 Johnson & Johnson Cognitive and Memory Enhancer Drugs Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Johnson & Johnson Products Offered 6.6.5 Johnson & Johnson Recent Development 6.7 Takeda Pharmaceutical Company Limited 6.6.1 Takeda Pharmaceutical Company Limited Cognitive and Memory Enhancer Drugs Production Sites and Area Served 6.6.2 Takeda Pharmaceutical Company Limited Description, Business Overview and Total Revenue 6.6.3 Takeda Pharmaceutical Company Limited Cognitive and Memory Enhancer Drugs Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Takeda Pharmaceutical Company Limited Products Offered 6.7.5 Takeda Pharmaceutical Company Limited Recent Development 6.8 AlternaScript 6.8.1 AlternaScript Cognitive and Memory Enhancer Drugs Production Sites and Area Served 6.8.2 AlternaScript Description, Business Overview and Total Revenue 6.8.3 AlternaScript Cognitive and Memory Enhancer Drugs Sales, Revenue and Gross Margin (2015-2020) 6.8.4 AlternaScript Products Offered 6.8.5 AlternaScript Recent Development 6.9 Cephalon 6.9.1 Cephalon Cognitive and Memory Enhancer Drugs Production Sites and Area Served 6.9.2 Cephalon Description, Business Overview and Total Revenue 6.9.3 Cephalon Cognitive and Memory Enhancer Drugs Sales, Revenue and Gross Margin (2015-2020) 6.9.4 Cephalon Products Offered 6.9.5 Cephalon Recent Development 6.10 Ceretropic 6.10.1 Ceretropic Cognitive and Memory Enhancer Drugs Production Sites and Area Served 6.10.2 Ceretropic Description, Business Overview and Total Revenue 6.10.3 Ceretropic Cognitive and Memory Enhancer Drugs Sales, Revenue and Gross Margin (2015-2020) 6.10.4 Ceretropic Products Offered 6.10.5 Ceretropic Recent Development 7 Cognitive and Memory Enhancer Drugs Manufacturing Cost Analysis 7.1 Cognitive and Memory Enhancer Drugs Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Cognitive and Memory Enhancer Drugs 7.4 Cognitive and Memory Enhancer Drugs Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Cognitive and Memory Enhancer Drugs Distributors List 8.3 Cognitive and Memory Enhancer Drugs Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Cognitive and Memory Enhancer Drugs Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Cognitive and Memory Enhancer Drugs by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Cognitive and Memory Enhancer Drugs by Type (2021-2026) 10.2 Cognitive and Memory Enhancer Drugs Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Cognitive and Memory Enhancer Drugs by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Cognitive and Memory Enhancer Drugs by Application (2021-2026) 10.3 Cognitive and Memory Enhancer Drugs Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Cognitive and Memory Enhancer Drugs by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Cognitive and Memory Enhancer Drugs by Region (2021-2026) 10.4 North America Cognitive and Memory Enhancer Drugs Estimates and Projections (2021-2026) 10.5 Europe Cognitive and Memory Enhancer Drugs Estimates and Projections (2021-2026) 10.6 Asia Pacific Cognitive and Memory Enhancer Drugs Estimates and Projections (2021-2026) 10.7 Latin America Cognitive and Memory Enhancer Drugs Estimates and Projections (2021-2026) 10.8 Middle East and Africa Cognitive and Memory Enhancer Drugs Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Cognitive and Memory Enhancer Drugs Sales (K Units) Growth Rate Comparison by Type (2015-2026) Table 2. Global Cognitive and Memory Enhancer Drugs Sales (K Units) Comparison by Application: 2020 VS 2026 Table 3. Global Cognitive and Memory Enhancer Drugs Market Size by Type (K Units) (US$ Million) (2020 VS 2026) Table 4. Global Key Cognitive and Memory Enhancer Drugs Manufacturers Covered in This Study Table 5. Global Cognitive and Memory Enhancer Drugs Sales (K Units) by Manufacturers (2015-2020) Table 6. Global Cognitive and Memory Enhancer Drugs Sales Share by Manufacturers (2015-2020) Table 7. Global Cognitive and Memory Enhancer Drugs Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Cognitive and Memory Enhancer Drugs Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Cognitive and Memory Enhancer Drugs Average Price (USD/Unit) of Key Manufacturers (2015-2020) Table 10. Manufacturers Cognitive and Memory Enhancer Drugs Sales Sites and Area Served Table 11. Manufacturers Cognitive and Memory Enhancer Drugs Product Types Table 12. Global Cognitive and Memory Enhancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Cognitive and Memory Enhancer Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cognitive and Memory Enhancer Drugs as of 2019) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Cognitive and Memory Enhancer Drugs Players Table 16. Global Cognitive and Memory Enhancer Drugs Sales (K Units) by Region (2015-2020) Table 17. Global Cognitive and Memory Enhancer Drugs Sales Market Share by Region (2015-2020) Table 18. Global Cognitive and Memory Enhancer Drugs Revenue (Million US$) by Region (2015-2020) Table 19. Global Cognitive and Memory Enhancer Drugs Revenue Market Share by Region (2015-2020) Table 20. North America Cognitive and Memory Enhancer Drugs Sales by Country (2015-2020) (K Units) Table 21. North America Cognitive and Memory Enhancer Drugs Sales Market Share by Country (2015-2020) Table 22. North America Cognitive and Memory Enhancer Drugs Revenue by Country (2015-2020) (US$ Million) Table 23. North America Cognitive and Memory Enhancer Drugs Revenue Market Share by Country (2015-2020) Table 24. Europe Cognitive and Memory Enhancer Drugs Sales by Country (2015-2020) (K Units) Table 25. Europe Cognitive and Memory Enhancer Drugs Sales Market Share by Country (2015-2020) Table 26. Europe Cognitive and Memory Enhancer Drugs Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Cognitive and Memory Enhancer Drugs Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Cognitive and Memory Enhancer Drugs Sales by Region (2015-2020) (K Units) Table 29. Asia Pacific Cognitive and Memory Enhancer Drugs Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Cognitive and Memory Enhancer Drugs Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Cognitive and Memory Enhancer Drugs Revenue Market Share by Region (2015-2020) Table 32. Latin America Cognitive and Memory Enhancer Drugs Sales by Country (2015-2020) (K Units) Table 33. Latin America Cognitive and Memory Enhancer Drugs Sales Market Share by Country (2015-2020) Table 34. Latin America Cognitive and Memory Enhancer Drugs Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Cognitive and Memory Enhancer Drugs Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Cognitive and Memory Enhancer Drugs Sales by Country (2015-2020) (K Units) Table 37. Middle East and Africa Cognitive and Memory Enhancer Drugs Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Cognitive and Memory Enhancer Drugs Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Cognitive and Memory Enhancer Drugs Revenue Market Share by Country (2015-2020) Table 40. Global Cognitive and Memory Enhancer Drugs Sales (K Units) by Type (2015-2020) Table 41. Global Cognitive and Memory Enhancer Drugs Sales Share by Type (2015-2020) Table 42. Global Cognitive and Memory Enhancer Drugs Revenue (Million US$) by Type (2015-2020) Table 43. Global Cognitive and Memory Enhancer Drugs Revenue Share by Type (2015-2020) Table 44. Global Cognitive and Memory Enhancer Drugs Price (USD/Unit) by Type (2015-2020) Table 45. Global Cognitive and Memory Enhancer Drugs Sales (K Units) by Application (2015-2020) Table 46. Global Cognitive and Memory Enhancer Drugs Sales Market Share by Application (2015-2020) Table 47. Global Cognitive and Memory Enhancer Drugs Sales Growth Rate by Application (2015-2020) Table 48. Pfizer Cognitive and Memory Enhancer Drugs Corporation Information Table 49. Pfizer Description and Business Overview Table 50. Pfizer Cognitive and Memory Enhancer Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 51. Pfizer Main Product Table 52. Pfizer Recent Development Table 53. Eisai Co Cognitive and Memory Enhancer Drugs Corporation Information Table 54. Eisai Co Corporation Information Table 55. Eisai Co Cognitive and Memory Enhancer Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 56. Eisai Co Main Product Table 57. Eisai Co Recent Development Table 58. Allergan Cognitive and Memory Enhancer Drugs Corporation Information Table 59. Allergan Corporation Information Table 60. Allergan Cognitive and Memory Enhancer Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 61. Allergan Main Product Table 62. Allergan Recent Development Table 63. Novartis Cognitive and Memory Enhancer Drugs Corporation Information Table 64. Novartis Corporation Information Table 65. Novartis Cognitive and Memory Enhancer Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 66. Novartis Main Product Table 67. Novartis Recent Development Table 68. Takeda Cognitive and Memory Enhancer Drugs Corporation Information Table 69. Takeda Corporation Information Table 70. Takeda Cognitive and Memory Enhancer Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 71. Takeda Main Product Table 72. Takeda Recent Development Table 73. Johnson & Johnson Cognitive and Memory Enhancer Drugs Corporation Information Table 74. Johnson & Johnson Corporation Information Table 75. Johnson & Johnson Cognitive and Memory Enhancer Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 76. Johnson & Johnson Main Product Table 77. Johnson & Johnson Recent Development Table 78. Takeda Pharmaceutical Company Limited Cognitive and Memory Enhancer Drugs Corporation Information Table 79. Takeda Pharmaceutical Company Limited Corporation Information Table 80. Takeda Pharmaceutical Company Limited Cognitive and Memory Enhancer Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 81. Takeda Pharmaceutical Company Limited Main Product Table 82. Takeda Pharmaceutical Company Limited Recent Development Table 83. AlternaScript Cognitive and Memory Enhancer Drugs Corporation Information Table 84. AlternaScript Corporation Information Table 85. AlternaScript Cognitive and Memory Enhancer Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 86. AlternaScript Main Product Table 87. AlternaScript Recent Development Table 88. Cephalon Cognitive and Memory Enhancer Drugs Corporation Information Table 89. Cephalon Corporation Information Table 90. Cephalon Cognitive and Memory Enhancer Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 91. Cephalon Main Product Table 92. Cephalon Recent Development Table 93. Ceretropic Cognitive and Memory Enhancer Drugs Corporation Information Table 94. Ceretropic Corporation Information Table 95. Ceretropic Cognitive and Memory Enhancer Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 96. Ceretropic Main Product Table 97. Ceretropic Recent Development Table 98. Sales Base and Market Concentration Rate of Raw Material Table 99. Key Suppliers of Raw Materials Table 100. Cognitive and Memory Enhancer Drugs Distributors List Table 101. Cognitive and Memory Enhancer Drugs Customers List Table 102. Market Key Trends Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 104. Key Challenges Table 105. Global Cognitive and Memory Enhancer Drugs Sales (K Units) Forecast by Type (2021-2026) Table 106. Global Cognitive and Memory Enhancer Drugs Sales Market Share Forecast by Type (2021-2026) Table 107. Global Cognitive and Memory Enhancer Drugs Revenue (Million US$) Forecast by Type (2021-2026) Table 108. Global Cognitive and Memory Enhancer Drugs Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 109. Global Cognitive and Memory Enhancer Drugs Sales (K Units) Forecast by Application (2021-2026) Table 110. Global Cognitive and Memory Enhancer Drugs Revenue (Million US$) Forecast by Application (2021-2026) Table 111. Global Cognitive and Memory Enhancer Drugs Sales (K Units) Forecast by Region (2021-2026) Table 112. Global Cognitive and Memory Enhancer Drugs Sales Market Share Forecast by Region (2021-2026) Table 113. Global Cognitive and Memory Enhancer Drugs Revenue Forecast by Region (2021-2026) (US$ Million) Table 114. Global Cognitive and Memory Enhancer Drugs Revenue Market Share Forecast by Region (2021-2026) Table 115. Research Programs/Design for This Report Table 116. Key Data Information from Secondary Sources Table 117. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Cognitive and Memory Enhancer Drugs Figure 2. Global Cognitive and Memory Enhancer Drugs Sales Market Share by Type: 2020 VS 2026 Figure 3. Aricept Product Picture Figure 4. Exelon Product Picture Figure 5. Namenda Product Picture Figure 6. Razadyne Product Picture Figure 7. Provigil Product Picture Figure 8. Ritalin Product Picture Figure 9. Adderall Product Picture Figure 10. Others Product Picture Figure 11. Global Cognitive and Memory Enhancer Drugs Consumption Market Share by Application: 2020 VS 2026 Figure 12. Disease Treatment Figure 13. Academic Performance Figure 14. Athletic Performance Figure 15. Others Figure 16. Global Cognitive and Memory Enhancer Drugs Market Size 2015-2026 (US$ Million) Figure 17. Global Cognitive and Memory Enhancer Drugs Sales Capacity (K Units) (2015-2026) Figure 18. Global Cognitive and Memory Enhancer Drugs Market Size Market Share by Region: 2020 Versus 2026 Figure 19. Cognitive and Memory Enhancer Drugs Sales Share by Manufacturers in 2020 Figure 20. Global Cognitive and Memory Enhancer Drugs Revenue Share by Manufacturers in 2019 Figure 21. The Global 5 and 10 Largest Players: Market Share by Cognitive and Memory Enhancer Drugs Revenue in 2019 Figure 22. Cognitive and Memory Enhancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 23. Global Cognitive and Memory Enhancer Drugs Sales Market Share by Region (2015-2020) Figure 24. Global Cognitive and Memory Enhancer Drugs Sales Market Share by Region in 2019 Figure 25. Global Cognitive and Memory Enhancer Drugs Revenue Market Share by Region (2015-2020) Figure 26. Global Cognitive and Memory Enhancer Drugs Revenue Market Share by Region in 2019 Figure 27. North America Cognitive and Memory Enhancer Drugs Sales Market Share by Country in 2019 Figure 28. North America Cognitive and Memory Enhancer Drugs Revenue Market Share by Country in 2019 Figure 29. U.S. Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units) Figure 30. U.S. Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. Canada Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units) Figure 32. Canada Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. Europe Cognitive and Memory Enhancer Drugs Sales Market Share by Country in 2019 Figure 34. Europe Cognitive and Memory Enhancer Drugs Revenue Market Share by Country in 2019 Figure 35. Germany Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units) Figure 36. Germany Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. France Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units) Figure 38. France Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 39. U.K. Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units) Figure 40. U.K. Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 41. Italy Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units) Figure 42. Italy Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. Russia Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units) Figure 44. Russia Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. Asia Pacific Cognitive and Memory Enhancer Drugs Sales Market Share by Region in 2019 Figure 46. Asia Pacific Cognitive and Memory Enhancer Drugs Revenue Market Share by Region in 2019 Figure 47. China Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units) Figure 48. China Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Japan Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units) Figure 50. Japan Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. South Korea Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units) Figure 52. South Korea Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. India Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units) Figure 54. India Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Australia Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units) Figure 56. Australia Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Taiwan Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units) Figure 58. Taiwan Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Indonesia Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units) Figure 60. Indonesia Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Thailand Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units) Figure 62. Thailand Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. Malaysia Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units) Figure 64. Malaysia Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Philippines Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units) Figure 66. Philippines Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Vietnam Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units) Figure 68. Vietnam Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Latin America Cognitive and Memory Enhancer Drugs Sales Market Share by Country in 2019 Figure 70. Latin America Cognitive and Memory Enhancer Drugs Revenue Market Share by Country in 2019 Figure 71. Mexico Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units) Figure 72. Mexico Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Brazil Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units) Figure 74. Brazil Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Argentina Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units) Figure 76. Argentina Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Middle East and Africa Cognitive and Memory Enhancer Drugs Sales Market Share by Country in 2019 Figure 78. Middle East and Africa Cognitive and Memory Enhancer Drugs Revenue Market Share by Country in 2019 Figure 79. Turkey Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units) Figure 80. Turkey Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 81. Saudi Arabia Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units) Figure 82. Saudi Arabia Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 83. U.A.E Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units) Figure 84. U.A.E Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 85. Sales Market Share of Cognitive and Memory Enhancer Drugs by Type (2015-2020) Figure 86. Sales Market Share of Cognitive and Memory Enhancer Drugs by Type in 2019 Figure 87. Revenue Share of Cognitive and Memory Enhancer Drugs by Type (2015-2020) Figure 88. Revenue Market Share of Cognitive and Memory Enhancer Drugs by Type in 2019 Figure 89. Global Cognitive and Memory Enhancer Drugs Sales Growth by Type (2015-2020) (K Units) Figure 90. Global Cognitive and Memory Enhancer Drugs Sales Market Share by Application (2015-2020) Figure 91. Global Cognitive and Memory Enhancer Drugs Sales Market Share by Application in 2019 Figure 92. Global Revenue Share of Cognitive and Memory Enhancer Drugs by Application (2015-2020) Figure 93. Global Revenue Share of Cognitive and Memory Enhancer Drugs by Application in 2020 Figure 94. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Eisai Co Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. Allergan Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Takeda Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018 Figure 100. Takeda Pharmaceutical Company Limited Total Revenue (US$ Million): 2019 Compared with 2018 Figure 101. AlternaScript Total Revenue (US$ Million): 2019 Compared with 2018 Figure 102. Cephalon Total Revenue (US$ Million): 2019 Compared with 2018 Figure 103. Ceretropic Total Revenue (US$ Million): 2019 Compared with 2018 Figure 104. Price Trend of Key Raw Materials Figure 105. Manufacturing Cost Structure of Cognitive and Memory Enhancer Drugs Figure 106. Manufacturing Process Analysis of Cognitive and Memory Enhancer Drugs Figure 107. Cognitive and Memory Enhancer Drugs Industrial Chain Analysis Figure 108. Channels of Distribution Figure 109. Distributors Profiles Figure 110. Porter's Five Forces Analysis Figure 111. North America Cognitive and Memory Enhancer Drugs Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 112. North America Cognitive and Memory Enhancer Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 113. Europe Cognitive and Memory Enhancer Drugs Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 114. Europe Cognitive and Memory Enhancer Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 115. Latin America Cognitive and Memory Enhancer Drugs Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 116. Latin America Cognitive and Memory Enhancer Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 117. Middle East and Africa Cognitive and Memory Enhancer Drugs Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 118. Middle East and Africa Cognitive and Memory Enhancer Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 119. Asia Pacific Cognitive and Memory Enhancer Drugs Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 120. Asia Pacific Cognitive and Memory Enhancer Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 121. Bottom-up and Top-down Approaches for This Report Figure 122. Data Triangulation Figure 123. Key Executives Interviewed

Pfizer Eisai Co Allergan Novartis Takeda Johnson & Johnson Takeda Pharmaceutical Company Limited AlternaScript Cephalon Ceretropic